Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +1.9%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 151–161 of 161 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01918306	GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer	terminated	Phase 1 / Phase 2	11	Vanderbilt-Ingram Cancer CenterOTHER	1	Jun 27, 2017	clinicaltrials
NCT01151449	Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer	terminated	Phase 2	6	National Cancer Institute (NCI)NIH	1	Apr 11, 2017